Business4 sources
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
TechCrunch · By Ram Iyer ·
The Brief · written from 4 sources
- Isomorphic Labs, Alphabet's AI drug-discovery company, raised a $5 billion Series C led by Sequoia and Greenoaks.
- The round came about six months after a $2.1 billion raise and follows a $600 million raise in March 2025.
- The company has no approved drugs yet and plans to use the funding to move its drug candidates toward clinical trials.
Why it matters
It signals large investor backing for AI-driven drug design and a push to move candidates into clinical trials, which is the stage where AI-discovered drugs will be tested against real outcomes.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Timeline
Full coverage · 4 sources
- 11h ago ↗
- 11h ago ↗
AI News & Artificial Intelligence | TechCrunch
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
- 14h ago ↗
- 14h ago ↗
Bloomberg Technology
Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round